S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ERNA Eterna Therapeutics Inc

0.90

-0.04929 (-5.19%)

Nov 15 2024 - Closed

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

Eterna Therapeutics (NASDAQ:ERNA)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Eterna Therapeutics Charts.

Eterna Therapeutics (NASDAQ:ERNA)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Eterna Therapeutics Charts.

Eterna Therapeutics Inc News

Eterna Therapeutics Regains Compliance with NASDAQ for Continued Listing
Thursday 14 November 2024 (2 days ago) • GlobeNewswire Inc.

Form D - Notice of Exempt Offering of Securities
Thursday 14 November 2024 (2 days ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 12 November 2024 (3 days ago) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Tuesday 5 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 November 2024 (1 week ago) • Edgar (US Regulatory)

Eterna Therapeutics Completes Strategic Financial Restructuring with the Aim to Accelerate its Developmental Activities and Long-Term Success
Wednesday 30 October 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 29 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Eterna Therapeutics and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases
Thursday 17 October 2024 (4 weeks ago) • GlobeNewswire Inc.

Form PRE 14A - Other preliminary proxy statements
Friday 27 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 27 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 25 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 23 September 2024 (2 months ago) • Edgar (US Regulatory)

More Eterna Therapeutics Inc News Articles

Eterna Therapeutics

Bathurst Resources (PK)

iShares Trust iShares MS...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions